Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Taggart

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Cardiovascular Translational Research|July 4, 2012
Human cardiosphere-derived cells from patients with chronic ischaemic heart disease can be routinely expanded from atrial but not epicardial ventricular biopsiesHelen H L Chan, Zaal Meher Homji, Renata S M Gomes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2016
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel diseaseJavier Escaned, Adrian Banning, Vasim Farooq, et al.
Circulation|June 13, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
European Heart Journal|June 14, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Circulation|June 15, 2011
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research ConsortiumRoxana Mehran, Sunil V Rao, Deepak L Bhatt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 21, 2010
Guidelines on myocardial revascularization, , Philippe Kolh, et al.
Nature Communications|May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapiesJamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
European Heart Journal|August 31, 2010
Guidelines on myocardial revascularization, , William Wijns, et al.
European Heart Journal|October 7, 2021
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II studyAdrian P Banning, Patrick Serruys, Giovanni Luigi De Maria, et al.
Science Translational Medicine|January 5, 2018
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockadeAdel Samson, Karen J Scott, David Taggart, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Cardiovascular Translational Research|July 4, 2012
Human cardiosphere-derived cells from patients with chronic ischaemic heart disease can be routinely expanded from atrial but not epicardial ventricular biopsiesHelen H L Chan, Zaal Meher Homji, Renata S M Gomes, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 13, 2016
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel diseaseJavier Escaned, Adrian Banning, Vasim Farooq, et al.
Circulation|June 13, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
European Heart Journal|June 14, 2018
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentHector M Garcia-Garcia, Eugène P McFadden, Andrew Farb, et al.
Circulation|June 15, 2011
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research ConsortiumRoxana Mehran, Sunil V Rao, Deepak L Bhatt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 21, 2010
Guidelines on myocardial revascularization, , Philippe Kolh, et al.
Nature Communications|May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapiesJamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
European Heart Journal|August 31, 2010
Guidelines on myocardial revascularization, , William Wijns, et al.
European Heart Journal|October 7, 2021
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II studyAdrian P Banning, Patrick Serruys, Giovanni Luigi De Maria, et al.
Science Translational Medicine|January 5, 2018
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockadeAdel Samson, Karen J Scott, David Taggart, et al.
Pageof 8